文献速递肝病

脂肪酸通过干扰3-巯基丙酮酸硫转移酶/硫化氢通路促进脂肪性肝病

Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.
PubMed 文献 · Gut · 2017-09-06

研究探讨游离脂肪酸(FFAs)经调控3-巯基丙酮酸硫转移酶(MPST)促进非酒精性脂肪性肝病(NAFLD)的机制。肝细胞FFAs处理上调MPST表达(部分依赖NF-κB/p65),高脂饮食小鼠及NAFLD患者肝MPST表达显著升高;部分敲低或杂合缺失Mpst可显著改善小鼠肝脂肪变性,抑制MPST减少FFA诱导的L02细胞脂质积聚。MPST直接结合并负调控胱硫醚γ-裂解酶(CSE),抑制CSE/H2S通路,上调SREBP1c通路、JNK磷酸化及肝脏氧化应激,从而促进脂肪变性;MPST可能是NAFLD的潜在治疗靶点。

要点

  • NAFLD患者和高脂饮食小鼠肝脏MPST表达显著升高。
  • 部分敲低或杂合缺失Mpst可显著改善高脂饮食小鼠肝脂肪变性。
  • MPST直接结合并负调控CSE,抑制H2S产生,促进肝脂肪变性。

核心结论

  • 游离脂肪酸上调肝脏MPST表达,进而抑制CSE/H2S通路,导致NAFLD。
  • MPST可能是NAFLD的潜在治疗靶点。

研究设计与样本

  • 评估小鼠和NAFLD患者肝脏MPST表达。
  • 采用多种分子方法在体内和体外研究MPST调控对肝脏脂肪变性的影响。

主要发现

  • 体外FFAs处理肝细胞上调MPST表达,部分依赖NF-κB/p65。
  • 高脂饮食小鼠和NAFLD患者肝脏MPST表达显著升高。
  • 经腺病毒递送MPST短发夹RNA部分敲低MPST或Mpst基因杂合缺失,显著改善高脂饮食小鼠肝脂肪变性。
  • 抑制MPST也减少FFA诱导的L02细胞脂肪积聚。
  • 抑制MPST显著增强而非减少H2S产生,而MPST过表达显著抑制H2S产生。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Accumulation of free fatty acids (FFAs) in hepatocytes induces lipotoxicity, leading to non-alcoholic fatty liver disease (NAFLD). This study aimed to investigate the underlying mechanisms by which FFA contributes to the pathogenesis of NAFLD via the regulation of 3-mercaptopyruvate sulfurtransferase (MPST), a key enzyme that regulates endogenous hydrogen sulfide (H2S) biosynthesis. DESIGN: Hepatic MPST expression was evaluated in mice and patients with NAFLD. A variety of molecular approaches were used to study the effects of MPST regulation on hepatic steatosis in vivo and in vitro. RESULTS: In vitro treatment of hepatocytes with FFAs upregulated MPST expression, which was partially dependent on NF-κB/p65. Hepatic MPST expression was markedly increased in high fat diet (HFD)-fed mice and patients with NAFLD. Partial knockdown of MPST via adenovirus delivery of MPST short hairpin RNA or heterozygous deletion of the Mpst gene significantly ameliorated hepatic steatosis in HFD-fed mice. Consistently, inhibition of MPST also reduced FFA-induced fat accumulation in L02 cells. Intriguingly, inhibition of MPST significantly enhanced rather than decreased H2S production, whereas MPST overexpression markedly inhibited H2S production. Co-immunoprecipitation experiments showed that MPST directly interacted with and negatively regulated cystathionine γ-lyase (CSE), a major source of H2S production in the liver. Mechanistically, MPST promoted steatosis via inhibition of CSE/H2S and subsequent upregulation of the sterol regulatory element-binding protein 1c pathway, C-Jun N-terminal kinase phosphorylation and hepatic oxidative stress. CONCLUSIONS: FFAs upregulate hepatic expression of MPST and subsequently inhibit the CSE/H2S pathway, leading to NAFLD. MPST may be a potential therapeutic target for NAFLD.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Li M, Xu C, Shi J, et al. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut. 2017. PMID: 28877979. doi:10.1136/gutjnl-2017-313778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。